ACSMX | NRGSX | ACSMX / NRGSX | |
Total Expense Ratio | 1.87 | 0.74 | 253% |
Annual Report Gross Expense Ratio | 1.87 | 0.74 | 253% |
Fund Existence | 5 years | 13 years | - |
Gain YTD | 4.174 | -3.902 | -107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111M | 8.71B | 1% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 2.46 | -10.12 | -24% |
Returns for 3 years | 45.28 | 5.90 | 767% |
Returns for 5 years | N/A | -2.32 | - |
Returns for 10 years | N/A | 10.24 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSBWX | 11.36 | 0.08 | +0.71% |
Morgan Stanley American Resilience C | |||
FGTAX | 29.68 | 0.14 | +0.47% |
Fidelity Advisor Mega Cap Stock A | |||
IJEAX | 11.24 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity A | |||
PHLAX | 36.77 | -0.05 | -0.14% |
PGIM Jennison Health Sciences A | |||
AIOCX | 10.29 | -0.05 | -0.48% |
American Century International Opps C |